Idt Australia Limited · ASX:IDT
Idt Australia — H1 FY20 Earnings Presentation
7 slides from Idt Australia's earnings presentation, Feb 21, 2020
Slide 1: IDT Australia Limited 2020 Interim Results
IDT AUSTRALIA LIMITED 2020 INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2019 21 February 2020
Slide 2: Interim Results H1 FY20 Highlights
2 Interim Results H1 FY20 Highlights Positive EBITDA of $0.6 Million for the period ended 31 December 2019 Including a one-time revenue adjustment, IDT generated a positive EBITDA of $0.6 million representing a year-on-year improvement of 155% ($1.1 million EBITDA loss reported as at 31 December 201
Slide 3: Interim Financial Results H1 FY20 Executive Summary
3 Interim Financial Results H1 FY20 HYE 31 HYE 31 Executive Summary Dec 2019 Dec 2018 $ 000 $ 000 Profitable EBITDAof $618K due to: Total Revenue 7,213 6,672 • Reported total revenue up 8% year-on-year • Revenue and improved gross margins underpinned Raw materials 768 1,216 by a focus on scalable an
Slide 4: IDT Base Business Operations H1 FY20 Year-on-Year Analysis
4 IDT Base Business Operations H1 FY20 Year-on-Year Analysis 51% Year-on-year reduction in net reported loss from operations: • $2.392m Reported loss before tax 31 December 2018 • $362K Improved gross margin • $583K Cost reduction initiatives • $1.447 Underlying loss before tax • $910K One-time reve
Slide 5: The Year Ahead – Half Year Check-in
5 The Year Ahead – Half Year Check-in [Slide presented at IDT’s 2019 Annual General Meeting] Drive and Grow The Continued Focus on Roll-out Medicinal Medicinal cannabis Business Capital Management and Cannabis Manufacturing biomass supply and Cost Containment Plan commercialisation Year-on-yea
Slide 6: IDT Australia Limited Board of Directors Executive Team
6 IDT Australia Limited Board of Directors Executive Team Mr Alan Fisher Chair Dr David Sparling CEO Finance specialist with key experience More than 20 years of pharma anddiagnostic experience in in business restructuring andcompany CEO,Director andcorporate/business development roles. turnarounds.
Slide 7: Disclaimer
6 DISCLAIMER This presentation contains forward looking statements which involve known and unknown risks. By their nature, forward looking statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors which could cause actualresults and dev